Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 479 articles:
HTML format
Text format



Single Articles


    January 2019
  1. LIN T, Li K, He W, Chen L, et al
    Trimethylamine N-oxide: A new therapeutic target for atrial fibrillation?
    Int J Cardiol. 2019;274:194.
    PubMed     Text format    


    December 2018
  2. IMAMURA T, Sumitomo N, Muraji S, Mori H, et al
    The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles.
    Int J Cardiol. 2018 Dec 27. pii: S0167-5273(18)35565.
    PubMed     Text format     Abstract available


  3. FENDER AC
    Connecting atrial morphology with platelet reactivity: What the left atrial appendage can tell us about the procoagulant state in atrial fibrillation.
    Int J Cardiol. 2018 Dec 20. pii: S0167-5273(18)36914.
    PubMed     Text format    


  4. LIN R, Zeng C, Xu K, Wu S, et al
    Dispersion-guided ablation in conjunction with circumferential pulmonary vein isolation is superior to stepwise ablation approach for persistent atrial fibrillation.
    Int J Cardiol. 2018 Dec 19. pii: S0167-5273(18)36189.
    PubMed     Text format     Abstract available


  5. KIM IS, Yang PS, Lee J, Yu HT, et al
    Long-term exposure of fine particulate matter air pollution and incident atrial fibrillation in the general population: A nationwide cohort study.
    Int J Cardiol. 2018 Dec 19. pii: S0167-5273(18)34120.
    PubMed     Text format     Abstract available


  6. ATHANASSOPOULOS GD, Armenis I
    Secondary stroke prevention in atrial fibrillation: Still lacking pace?
    Int J Cardiol. 2018 Dec 15. pii: S0167-5273(18)36306.
    PubMed     Text format    


  7. LINZ D, Kalman JM, R Doug M, Sanders P, et al
    CPAP initiation in persistent atrial fibrillation: Have we overslept the alarm clock?
    Int J Cardiol. 2018 Dec 13. pii: S0167-5273(18)36832.
    PubMed     Text format    


  8. AKHTAR MM, Elliott P
    Impact of left bundle branch block (LBBB) in dilated cardiomyopathy (DCM) with intermediate left ventricular systolic dysfunction (LVSD).
    Int J Cardiol. 2018 Dec 12. pii: S0167-5273(18)36414.
    PubMed     Text format    


  9. SONI A, Karna S, Fahey N, Sanghai S, et al
    Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study.
    Int J Cardiol. 2018 Dec 6. pii: S0167-5273(18)36009.
    PubMed     Text format     Abstract available


  10. SPARTALIS M, Tzatzaki E, Paschou SA, Spartalis E, et al
    Type 1 diabetes is associated with increased risk of atrial fibrillation.
    Int J Cardiol. 2018 Dec 4. pii: S0167-5273(18)34989.
    PubMed     Text format    


  11. CICONTE G
    Second-generation cryo-pulmonary vein isolation for persistent atrial fibrillation: Is it really time to think out of the 'veins'?
    Int J Cardiol. 2018 Dec 3. pii: S0167-5273(18)36270.
    PubMed     Text format    


  12. DAHME T
    Cryoballoon ablation in high versus low volume centers - Does experience make a difference?
    Int J Cardiol. 2018;272:227-228.
    PubMed     Text format    


  13. HUIKURI H, Buxton AE
    Identification of suitable patients for ICD therapy.
    Int J Cardiol. 2018;272:217-218.
    PubMed     Text format    


  14. EHRLICH JR, Look C, Kostev K, Israel CW, et al
    Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany.
    Int J Cardiol. 2018 Dec 1. pii: S0167-5273(18)34728.
    PubMed     Text format     Abstract available


    November 2018
  15. BORSCHEL CS, Schnabel RB
    The imminent epidemic of atrial fibrillation and its concomitant diseases - Myocardial infarction and heart failure - A cause for concern.
    Int J Cardiol. 2018 Nov 30. pii: S0167-5273(18)32280.
    PubMed     Text format     Abstract available


  16. FERREIRO JL, Gomez-Hospital JA
    Antithrombotic therapy after acute coronary syndromes in patients with atrial fibrillation: Shouldn't we pay more attention to the risk of ischemic and thromboembolic events?
    Int J Cardiol. 2018 Nov 29. pii: S0167-5273(18)36183.
    PubMed     Text format    


  17. BERGER WR, Meulendijks ER, Limpens J, van den Berg NWE, et al
    Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies.
    Int J Cardiol. 2018 Nov 29. pii: S0167-5273(18)33554.
    PubMed     Text format     Abstract available


  18. DENG H, Wu S
    What can we use to predict late recurrence after catheter ablation of atrial fibrillation?
    Int J Cardiol. 2018 Nov 26. pii: S0167-5273(18)35383.
    PubMed     Text format    


  19. CAPLES SM, Mansukhani MP, Friedman PA, Somers VK, et al
    The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: A randomized controlled trial.
    Int J Cardiol. 2018 Nov 20. pii: S0167-5273(18)36067.
    PubMed     Text format     Abstract available


  20. SALCEDO J, Hay JW, Lam J
    Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function.
    Int J Cardiol. 2018 Nov 19. pii: S0167-5273(18)34192.
    PubMed     Text format     Abstract available


  21. LINZ D, Elliott AD, Hohl M, Malik V, et al
    Role of autonomic nervous system in atrial fibrillation.
    Int J Cardiol. 2018 Nov 18. pii: S0167-5273(18)31862.
    PubMed     Text format     Abstract available


  22. GUO Y, Gao J, Ye P, Xing A, et al
    Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study.
    Int J Cardiol. 2018 Nov 17. pii: S0167-5273(18)36176.
    PubMed     Text format     Abstract available


  23. KOSIUK J, Uhe T, Stegmann C, Ueberham L, et al
    Morphological determinators of platelet activation status in patients with atrial fibrillation.
    Int J Cardiol. 2018 Nov 17. pii: S0167-5273(18)34874.
    PubMed     Text format     Abstract available


  24. WANG H, Wang S, Sun Y
    Could red blood cell distribution width predict high CHADS2 and CHADS2-VASC score in adults with atrial fibrillation? A focus on the general population.
    Int J Cardiol. 2018;271:345.
    PubMed     Text format    


  25. AMIN AS, Wilde AAM, Tan HL
    Response to letter from Drs. Li et al. regarding our paper in Int. J. Cardiol. 2018. Doi: 10.1016/j.ijcard.2017.09.010: SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Int J Cardiol. 2018;271:124.
    PubMed     Text format    


  26. WANG Y, Wang C, Zhang Y, Hong F, et al
    The new evidence on cryoballoon ablation to persistent atrial fibrillation.
    Int J Cardiol. 2018;271:121.
    PubMed     Text format    


  27. JIANG P, Wu J, Guo S, He Y, et al
    Atrial fibrillation and sleep apnea: A chicken and egg situation.
    Int J Cardiol. 2018;271:120.
    PubMed     Text format    


  28. LI J, Wang X, Sun M, Yan G, et al
    "Rebound" hypercoagulability after interruption of anticoagulation in patients with atrial fibrillation.
    Int J Cardiol. 2018;271:119.
    PubMed     Text format    


  29. HU Z, Zhang M, Li B, Hong J, et al
    The emergence of clarifying the role of gut microbes in arrhythmia.
    Int J Cardiol. 2018;271:348.
    PubMed     Text format    


  30. LI X, Shang H, Xing Y
    New risk stratification on SCN5A mutation in Brugada syndrome.
    Int J Cardiol. 2018;271:123.
    PubMed     Text format    


  31. MENG G, Wang M, Zhou L, Yu L, et al
    Reply: The emergence of clarifying the role of gut microbes in arrhythmia.
    Int J Cardiol. 2018;271:122.
    PubMed     Text format    


  32. BORIANI G, Diemberger I
    A closer look into the complexity of our practice: Outcome research for transvenous temporary cardiac pacing.
    Int J Cardiol. 2018;271:117-118.
    PubMed     Text format    


  33. CORONEL R
    Activation-repolarization mapping to guide VT-ablation without the need to induce the arrhythmia.
    Int J Cardiol. 2018;271:111-112.
    PubMed     Text format    


  34. SCHUPP T, Behnes M, Reiser L, Bollow A, et al
    Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias.
    Int J Cardiol. 2018 Nov 15. pii: S0167-5273(18)34572.
    PubMed     Text format     Abstract available


  35. GENTILE P, Paldino A, Cannata A, Artico J, et al
    Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: Clinical phenotyping and outcome correlates.
    Int J Cardiol. 2018 Nov 5. pii: S0167-5273(18)33321.
    PubMed     Text format     Abstract available


  36. WALTERS TE, Wick K, Tan G, Mearns M, et al
    Symptom severity and quality of life in patients with atrial fibrillation: Psychological function outweighs clinical predictors.
    Int J Cardiol. 2018 Nov 2. pii: S0167-5273(18)35308.
    PubMed     Text format     Abstract available


  37. PATTI G, Pecen L, Lucerna M, Huber K, et al
    Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Int J Cardiol. 2018;270:160-166.
    PubMed     Text format     Abstract available


  38. GUENANCIA C, Dargent A, Large A, Andreu P, et al
    New-onset atrial fibrillation in ICU: A FROG in the throat.
    Int J Cardiol. 2018;270:189.
    PubMed     Text format    


  39. MERT GO, Mert KU, Gorenek B
    Success predictor of cryoballoon ablation in atrial fibrillation: Left atrial volume vs area.
    Int J Cardiol. 2018;270:188.
    PubMed     Text format    


  40. KIMURA T, Kohno T, Fukunaga K, Yamasawa W, et al
    Author's reply: Atrial fibrillation and sleep apnea: A chicken and egg situation.
    Int J Cardiol. 2018;270:187.
    PubMed     Text format    


  41. POLZIN A, Dannenberg L, Wolff G, Zeus T, et al
    Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer?
    Int J Cardiol. 2018;270:82.
    PubMed     Text format    


  42. SAGUNER AM
    Making the invisible visible - Ultra-high-resolution mapping to identify residual pulmonary vein conduction immediately after cryoballoon-based pulmonary vein isolation.
    Int J Cardiol. 2018;270:180-182.
    PubMed     Text format    


    October 2018
  43. WATANABE E, Miyagawa M, Uetani T, Kinoshita M, et al
    Positron emission tomography/computed tomography detection of increased (18)F-fluorodeoxyglucose uptake in the cardiac atria of patients with atrial fibrillation.
    Int J Cardiol. 2018 Oct 31. pii: S0167-5273(18)34524.
    PubMed     Text format     Abstract available


  44. MORTSELL D, Jansson V, Malmborg H, Lonnerholm S, et al
    Clinical outcome of the 2nd generation cryoballoon for pulmonary vein isolation in patients with persistent atrial fibrillation - A sub-study of the randomized trial evaluating single versus dual cryoballoon applications.
    Int J Cardiol. 2018 Oct 29. pii: S0167-5273(18)35500.
    PubMed     Text format     Abstract available


  45. LEE Y, Park HC, Shin JH, Lim YH, et al
    Single and persistent elevation of C-reactive protein levels and the risk of atrial fibrillation in a general population: The Ansan-Ansung Cohort of the Korean Genome and Epidemiology Study.
    Int J Cardiol. 2018 Oct 28. pii: S0167-5273(18)34176.
    PubMed     Text format     Abstract available


  46. PROTONOTARIOS A, Wicks E, Ashworth M, Stephenson E, et al
    Prevalence of (18)F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2018 Oct 26. pii: S0167-5273(18)34604.
    PubMed     Text format     Abstract available


  47. MATARESE A, Sardu C, Shu J, Santulli G, et al
    Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms.
    Int J Cardiol. 2018 Oct 25. pii: S0167-5273(18)35646.
    PubMed     Text format    


  48. PROIETTI M
    Impact of hospitalization in patients with atrial fibrillation: Implications for health-care providers and clinical management.
    Int J Cardiol. 2018 Oct 23. pii: S0167-5273(18)35592.
    PubMed     Text format    


  49. TERESHCHENKO LG
    Left anterior fascicular block: The need for a re-appraisal.
    Int J Cardiol. 2018;269:31-32.
    PubMed     Text format    


  50. MOON I, Choi EK, Jung JH, Han KD, et al
    Ankylosing spondylitis: A novel risk factor for atrial fibrillation - A nationwide population-based study.
    Int J Cardiol. 2018 Oct 11. pii: S0167-5273(18)34136.
    PubMed     Text format     Abstract available


  51. RUSSO V, Solimene F, Zanotto G, Pisano EC, et al
    Seasonal trend of ventricular arrhythmias in a nationwide remote monitoring database of implantable defibrillators and cardiac resynchronization devices.
    Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)35326.
    PubMed     Text format     Abstract available


  52. SLUYTER JD, Camargo CA Jr, Lowe A, Scragg RKR, et al
    Pulse rate variability predicts atrial fibrillation and cerebrovascular events in a large, population-based cohort.
    Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)34448.
    PubMed     Text format     Abstract available


  53. SHULMAN E, Chudow JJ, Essien UR, Shanbhag A, et al
    Relative contribution of modifiable risk factors for incident atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)35024.
    PubMed     Text format     Abstract available


  54. SCOTT L JR, Li N, Dobrev D
    Role of inflammatory signaling in atrial fibrillation.
    Int J Cardiol. 2018 Oct 4. pii: S0167-5273(18)35864.
    PubMed     Text format     Abstract available


  55. TELLES-GARCIA N, Dahal K, Kocherla C, Lip GYH, et al
    Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2018;268:143-148.
    PubMed     Text format     Abstract available


  56. FANGEL MV, Nielsen PB, Larsen TB, Christensen B, et al
    Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
    Int J Cardiol. 2018;268:137-142.
    PubMed     Text format     Abstract available


  57. OWEN HJ, Bos JM, Ackerman MJ
    Wearable cardioverter defibrillators for patients with long QT syndrome.
    Int J Cardiol. 2018;268:132-136.
    PubMed     Text format     Abstract available


  58. XING Y, Xu B, Sheng X, Xu C, et al
    Transformation from persistent atrial fibrillation to paroxysmal type after initial ablation predicts success of repeated ablation.
    Int J Cardiol. 2018;268:120-124.
    PubMed     Text format     Abstract available


  59. DELISE P, Schwartz PJ
    Letter concerning the editorial by Giustetto et al. Int J Cardiol 2018;254:170-171.
    Int J Cardiol. 2018;268:155.
    PubMed     Text format    


  60. CALDEIRA D
    Non-vitamin K antagonist oral anticoagulants (NOACs) in cardioversions: The past, the present and the future.
    Int J Cardiol. 2018;268:149-150.
    PubMed     Text format    


    September 2018
  61. PAPAGEORGIOU N, Lim WY, Schilling RJ
    Atrial fibrillation in acute coronary syndromes: Could white blood cell count be the link?
    Int J Cardiol. 2018 Sep 21. pii: S0167-5273(18)34829.
    PubMed     Text format    


  62. LI YG, Lip GYH
    Stroke prevention in atrial fibrillation: State of the art.
    Int J Cardiol. 2018 Sep 19. pii: S0167-5273(18)32178.
    PubMed     Text format     Abstract available


  63. GUTTMANN OP
    Atrial fibrillation and thromboembolism in hypertrophic cardiomyopathy - An underestimated risk.
    Int J Cardiol. 2018 Sep 19. pii: S0167-5273(18)35180.
    PubMed     Text format    


  64. SVINGEN GFT, Zuo H, Ueland PM, Seifert R, et al
    Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.
    Int J Cardiol. 2018;267:100-106.
    PubMed     Text format     Abstract available


  65. HAUGAA KH, Stokke MK
    Cardiac electrical and mechanical alterations - united in the long QT syndrome.
    Int J Cardiol. 2018 Sep 15. pii: S0167-5273(18)34824.
    PubMed     Text format    


  66. GRYMONPREZ M, Vakaet V, Kavousi M, Stricker BH, et al
    Chronic obstructive pulmonary disease and the development of atrial fibrillation.
    Int J Cardiol. 2018 Sep 15. pii: S0167-5273(18)32860.
    PubMed     Text format     Abstract available


  67. STEWART COATS AJ
    The enigma of beta-blockers, atrial fibrillation and heart failure.
    Int J Cardiol. 2018 Sep 15. pii: S0167-5273(18)34869.
    PubMed     Text format    


  68. PENELA D, Mont L
    VT ablation and survival: A solved question?
    Int J Cardiol. 2018;267:118-119.
    PubMed     Text format    


  69. WEBER C, Hung J, Hickling S, Li I, et al
    Drivers of hospitalisation trends for non-valvular atrial fibrillation in Western Australia, 2000-2013.
    Int J Cardiol. 2018 Sep 13. pii: S0167-5273(18)33943.
    PubMed     Text format     Abstract available


  70. GIUDICESSI JR, Rohatgi RK, Bos JM, Ackerman MJ, et al
    Prevalence and clinical phenotype of concomitant long QT syndrome and arrhythmogenic bileaflet mitral valve prolapse.
    Int J Cardiol. 2018 Sep 11. pii: S0167-5273(18)34953.
    PubMed     Text format     Abstract available


  71. VAN DOORN S, Rutten FH, O'Flynn CM, Oudega R, et al
    Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.
    Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)33685.
    PubMed     Text format     Abstract available


  72. MARUM AA, Silva BA, Bortolotto AL, Silva AC, et al
    Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration.
    Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)34561.
    PubMed     Text format     Abstract available


  73. JENABI E
    Comment on "Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis".
    Int J Cardiol. 2018 Sep 5. pii: S0167-5273(18)34785.
    PubMed     Text format    


  74. BRIONGOS-FIGUERO S, Estevez A, Luisa Perez M, Martinez-Ferrer JB, et al
    Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Int J Cardiol. 2018 Sep 5. pii: S0167-5273(18)34159.
    PubMed     Text format     Abstract available


  75. ARRIGO M, Ishihara S, Feliot E, Rudiger A, et al
    New-onset atrial fibrillation in critically ill patients and its association with mortality: A report from the FROG-ICU study.
    Int J Cardiol. 2018;266:95-99.
    PubMed     Text format     Abstract available


  76. CASTELLETTI S, Dagradi F, Goulene K, Danza AI, et al
    A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome.
    Int J Cardiol. 2018;266:89-94.
    PubMed     Text format     Abstract available


  77. AESCHBACHER S, O'Neal WT, Krisai P, Loehr L, et al
    Relationship between QRS duration and incident atrial fibrillation.
    Int J Cardiol. 2018;266:84-88.
    PubMed     Text format     Abstract available


  78. NAKAMURA K, Funabashi N, Naito S, Uehara M, et al
    Reply to letter "anatomical relationship of coronary sinus/great cardiac vein and LCx artery along mitral annulus in atrial-fibrillation before radiofrequency catheter ablation using 320-slice CT".
    Int J Cardiol. 2018;266:160.
    PubMed     Text format    


  79. RIENSTRA M, van Veldhuisen DJ
    Atrial fibrillation is more troublesome in heart failure patients with preserved compared to those with reduced ejection fraction.
    Int J Cardiol. 2018;266:155-156.
    PubMed     Text format    


  80. KADHIM K, Lau DH, Linz D, Sanders P, et al
    Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
    Int J Cardiol. 2018;266:153-154.
    PubMed     Text format    


  81. STROKER E, de Asmundis C, Chierchia GB
    Cryoballoon ablation for the treatment of atrial fibrillation: Does it stand the test of time?
    Int J Cardiol. 2018;266:151-152.
    PubMed     Text format    


  82. BALIK M
    New-onset atrial fibrillation in critically ill patients - Implications for rhythm rather than rate control therapy?
    Int J Cardiol. 2018;266:147-148.
    PubMed     Text format    


  83. VERRIER RL
    The power of the patch: A smart way to track risk for Torsades de pointes in congenital and drug-induced long QT syndromes?
    Int J Cardiol. 2018;266:145-146.
    PubMed     Text format    


  84. HEIJMAN J, Dobrev D, Crijns HJGM
    Electrocardiographic characteristics associated with atrial fibrillation - What do they tell us?
    Int J Cardiol. 2018;266:143-144.
    PubMed     Text format    


  85. BARRA S, Baran J, Narayanan K, Boveda S, et al
    Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2018;266:136-142.
    PubMed     Text format     Abstract available


  86. RIVASI G, Solari D, Rafanelli M, Ceccofiglio A, et al
    Incidence and predictors of syncope recurrence after cardiac pacing in patients with carotid sinus syndrome.
    Int J Cardiol. 2018;266:119-123.
    PubMed     Text format     Abstract available


  87. GOYAL P, Almarzooq ZI, Cheung J, Kamel H, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
    Int J Cardiol. 2018;266:112-118.
    PubMed     Text format     Abstract available


  88. AKKAYA E, Berkowitsch A, Zaltsberg S, Greiss H, et al
    Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation.
    Int J Cardiol. 2018;266:106-111.
    PubMed     Text format     Abstract available


  89. GRIMALDI-BENSOUDA L, Wedemeyer H, Wiegand J, Lohse AW, et al
    Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study.
    Int J Cardiol. 2018;266:100-105.
    PubMed     Text format     Abstract available


  90. JONES DA, Rathod KS, Williamson A, Harrington D, et al
    The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.
    Int J Cardiol. 2018;266:1-6.
    PubMed     Text format     Abstract available


  91. LI YG, Miyazawa K, Wolff A, Zubaid M, et al
    One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Int J Cardiol. 2018 Sep 1. pii: S0167-5273(18)34355.
    PubMed     Text format     Abstract available


  92. CHEN HL, Cai JY, Zha ML, Liu K, et al
    Does CHA2DS2-VASc score have the discrimination and calibration power in predicting renal function decline?
    Int J Cardiol. 2018;266:161.
    PubMed     Text format    


  93. WANG S, Su Z, Zhang Y
    The true prevalence of inappropriate anticoagulation therapy in Chinese patients with a CHA2DS2-VASc score of 0.
    Int J Cardiol. 2018;266:159.
    PubMed     Text format    


    August 2018
  94. RAVERA M, Bussalino E, Paoletti E, Bellasi A, et al
    Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?
    Int J Cardiol. 2018 Aug 31. pii: S0167-5273(18)33747.
    PubMed     Text format     Abstract available


  95. HIGASHI Y
    Does renal function have incremental predictive value of stroke in atrial fibrillation?
    Int J Cardiol. 2018 Aug 29. pii: S0167-5273(18)34620.
    PubMed     Text format    


  96. GOEL A, Agnihotri K, Ashish K, Subramany S, et al
    Novel biomarkers for atrial fibrillation: A recent update.
    Int J Cardiol. 2018 Aug 25. pii: S0167-5273(18)34943.
    PubMed     Text format    


  97. CAMM CF, Russell E, Ji Xu A, Rajappan K, et al
    Does YouTube provide high-quality resources for patient education on atrial fibrillation ablation?
    Int J Cardiol. 2018 Aug 24. pii: S0167-5273(18)33338.
    PubMed     Text format     Abstract available


  98. PARK JW, Sievert H, Kleinecke C, Vaskelyte L, et al
    Left atrial appendage occlusion with lambre in atrial fibrillation: Initial European experience.
    Int J Cardiol. 2018;265:97-102.
    PubMed     Text format     Abstract available


  99. CHAN YH, Yeh YH, Hsieh MY, Chang CY, et al
    The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan.
    Int J Cardiol. 2018;265:83-89.
    PubMed     Text format     Abstract available


  100. JIANG P, Yang FO, Wu J, He Y, et al
    Left atrial low-voltage areas: A powerful predictor in paroxysmal atrial fibrillation recurrence after catheter ablation?
    Int J Cardiol. 2018;265:238.
    PubMed     Text format    


  101. MASUDA M
    Reply to the letter to the editor: "Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation".
    Int J Cardiol. 2018;265:134.
    PubMed     Text format    


  102. PATTI G, Cavallari I, Hanon O, De Caterina R, et al
    The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly.
    Int J Cardiol. 2018;265:118-124.
    PubMed     Text format     Abstract available


  103. KATSIKI N, Mikhailidis DP, Papanas N
    Left atrial volume: An independent predictor of cardiovascular outcomes.
    Int J Cardiol. 2018;265:234-235.
    PubMed     Text format    


  104. EMDIN M, Aimo A, Mirizzi G, Piacenti M, et al
    Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox.
    Int J Cardiol. 2018;265:169-170.
    PubMed     Text format    


  105. CHANG TY, Lin CY, Chen SA
    Vagal impact of cryoballoon ablation during pulmonary vein isolation.
    Int J Cardiol. 2018;265:132-133.
    PubMed     Text format    


  106. SAMANTA R, Pouliopoulos J, Kumar S, Narayan A, et al
    Influence of BMI on inducible ventricular tachycardia and mortality in patients with myocardial infarction and left ventricular dysfunction: The obesity paradox.
    Int J Cardiol. 2018;265:148-154.
    PubMed     Text format     Abstract available


  107. MIYAZAKI S, Kajiyama T, Watanabe T, Hada M, et al
    Atrioventricular conduction disturbance during pulmonary vein isolation using the second-generation cryoballoon - Vagal impact of cryoballoon ablation.
    Int J Cardiol. 2018;265:113-117.
    PubMed     Text format     Abstract available


  108. DE SENSI F, Berruezo A
    Pulmonary vein potentials during cryoballoon ablation of atrial fibrillation. If you don't see them, look forward...and make a good lesion!
    Int J Cardiol. 2018 Aug 13. pii: S0167-5273(18)34451.
    PubMed     Text format    


  109. MCCABE PJ
    Moving beyond description to intervention to improve self-management knowledge for patients with atrial fibrillation.
    Int J Cardiol. 2018 Aug 13. pii: S0167-5273(18)34436.
    PubMed     Text format    


  110. BOGEHOLZ N, Dechering DG, Eckardt L
    Improved risk stratification for patients with atrial fibrillation by advancing the concept of atrial cardiomyopathy?
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)34360.
    PubMed     Text format    


  111. POTPARA TS, Mujovic N, Sivasambu B, Shantsila A, et al
    Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation.
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)34388.
    PubMed     Text format     Abstract available


  112. CHOI YJ, Choi EK, Han KD, Jung JH, et al
    Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)33740.
    PubMed     Text format     Abstract available


  113. BARANCHUK A, Yeung C
    Advanced interatrial block predicts atrial fibrillation recurrence across different populations: Learning Bayes syndrome.
    Int J Cardiol. 2018 Aug 10. pii: S0167-5273(18)34711.
    PubMed     Text format    


  114. PAVLICEK V, Kindermann I, Wintrich J, Mahfoud F, et al
    Ventricular arrhythmias and myocardial inflammation: Long-term follow-up of patients with suspected myocarditis.
    Int J Cardiol. 2018 Aug 9. pii: S0167-5273(18)31893.
    PubMed     Text format     Abstract available


  115. CAMPODONICO J, Piepoli M, Clemenza F, Bonomi A, et al
    Dose-dependent efficacy of beta-blocker in patients with chronic heart failure and atrial fibrillation.
    Int J Cardiol. 2018 Aug 6. pii: S0167-5273(18)34278.
    PubMed     Text format     Abstract available


  116. RUBBOLI A
    Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
    Int J Cardiol. 2018;264:95-96.
    PubMed     Text format    


  117. FRIBERG L
    Safety of apixaban in combination with dronedarone in patients with atrial fibrillation.
    Int J Cardiol. 2018;264:85-90.
    PubMed     Text format     Abstract available


  118. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
    Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
    Int J Cardiol. 2018;264:64-69.
    PubMed     Text format     Abstract available


  119. PASTORI D, Lip GYH, Farcomeni A, Del Sole F, et al
    Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
    Int J Cardiol. 2018;264:58-63.
    PubMed     Text format     Abstract available


  120. EL-BATTRAWY I, Borggrefe M, Akin I
    Sleep apnea as an attributable risk for atrial fibrillation.
    Int J Cardiol. 2018;264:103.
    PubMed     Text format    


  121. POPPE KK, Doughty RN
    Response to letter from El-Battrawy et al.: Sleep apnea as an attributable risk for atrial fibrillation.
    Int J Cardiol. 2018;264:102.
    PubMed     Text format    


  122. OZEKE O, Aras D, Cay S, Ozcan F, et al
    Ajmaline-induced Epsilon wave: Its role is not only for diagnosis but also for risk stratification.
    Int J Cardiol. 2018;264:99.
    PubMed     Text format    


  123. EHRLICH JR
    Re-gaining confidence in contemporary dronedarone use.
    Int J Cardiol. 2018;264:97-98.
    PubMed     Text format    


  124. MARIN F, Roldan V
    Oral anticoagulation and comorbidities; too many details for clinical practice?
    Int J Cardiol. 2018;264:93-94.
    PubMed     Text format    


  125. THERASSE D, Probst V, Gourraud JB
    Sodium channel blocker challenge in Brugada syndrome: Role in risk stratification.
    Int J Cardiol. 2018;264:100-101.
    PubMed     Text format    


  126. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Cushman M, et al
    The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Int J Cardiol. 2018;264:158-164.
    PubMed     Text format     Abstract available


  127. CHAUHAN RA, Coote J, Allen E, Pongpaopattanakul P, et al
    Functional selectivity of cardiac preganglionic sympathetic neurones in the rabbit heart.
    Int J Cardiol. 2018;264:70-78.
    PubMed     Text format     Abstract available


  128. DESAI R, Patel U, Deshmukh A, Sachdeva R, et al
    Burden of arrhythmia in recreational marijuana users.
    Int J Cardiol. 2018;264:91-92.
    PubMed     Text format     Abstract available


    July 2018
  129. D'ONOFRIO A, Pieragnoli P, Biffi M, Nigro G, et al
    Subcutaneous implantable cardioverter defibrillator implantation: An analysis of Italian clinical practice and its evolution.
    Int J Cardiol. 2018 Jul 31. pii: S0167-5273(18)33995.
    PubMed     Text format     Abstract available


  130. VEDOVATI MC, Giustozzi M, Verdecchia P, Pierpaoli L, et al
    Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
    Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)32719.
    PubMed     Text format     Abstract available


  131. FUJIMOTO Y, Yodogawa K, Maru YJ, Oka E, et al
    Advanced interatrial block is an electrocardiographic marker for recurrence of atrial fibrillation after electrical cardioversion.
    Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)33748.
    PubMed     Text format     Abstract available


  132. MCALISTER FA, Wiebe N, Ronksley PE, Healey JS, et al
    Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.
    Int J Cardiol. 2018 Jul 27. pii: S0167-5273(18)33059.
    PubMed     Text format     Abstract available


  133. LINZ D, Kadhim K, Brooks AG, Elliott AD, et al
    Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)32387.
    PubMed     Text format     Abstract available


  134. MUJOVIC N, Potpara TS
    Predicting incident atrial fibrillation in patients with diabetes mellitus.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)34293.
    PubMed     Text format    


  135. O'BRIEN EC, Holmes DN, Thomas L, Singer DE, et al
    Incremental prognostic value of renal function for stroke prediction in atrial fibrillation.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)31273.
    PubMed     Text format     Abstract available


  136. MIYAZAWA K, Li YG, Rashed WA, Al Mahmeed W, et al
    Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE).
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)33607.
    PubMed     Text format     Abstract available


  137. BASKAR S, Veldtman GR, Khoury PR, Opotowsky AR, et al
    Characteristics of hospital admissions associated with implantable cardioverter defibrillator placement among adults with congenital heart disease.
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)32840.
    PubMed     Text format     Abstract available


  138. SMITH ED, Tome J, Mcgrath R, Kumar S, et al
    Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death.
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)33053.
    PubMed     Text format     Abstract available


  139. WANDELL P, Carlsson AC, Sundquist J, Sundquist K, et al
    Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation.
    Int J Cardiol. 2018 Jul 21. pii: S0167-5273(18)32760.
    PubMed     Text format     Abstract available


  140. ARRIGO M, Feliot E, Gayat E, Mebazaa A, et al
    Cardiovascular events after ICU discharge in patients with new-onset atrial fibrillation: A report from the FROG-ICU study.
    Int J Cardiol. 2018 Jul 20. pii: S0167-5273(18)34103.
    PubMed     Text format    


  141. STABILE G, Tondo C, Curnis A, Lunati M, et al
    Efficacy of cryoballoon ablation in patients with paroxysmal atrial fibrillation without time to pulmonary vein isolation assessment.
    Int J Cardiol. 2018 Jul 20. pii: S0167-5273(18)32170.
    PubMed     Text format     Abstract available


  142. WANG XH, Li Z, Mao JL, Zang MH, et al
    Low voltage areas in paroxysmal atrial fibrillation: The prevalence, risk factors and impact on the effectiveness of catheter ablation.
    Int J Cardiol. 2018 Jul 19. pii: S0167-5273(18)33797.
    PubMed     Text format     Abstract available


  143. LANDOLINA M, Arena G, Iacopino S, Verlato R, et al
    Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: Data on 860 patients from the real-world multicenter observational project.
    Int J Cardiol. 2018 Jul 18. pii: S0167-5273(18)30400.
    PubMed     Text format     Abstract available


  144. DESTEGHE L, Germeys J, Vijgen J, Koopman P, et al
    Effectiveness and usability of an online tailored education platform for atrial fibrillation patients undergoing a direct current cardioversion or pulmonary vein isolation.
    Int J Cardiol. 2018 Jul 17. pii: S0167-5273(18)33446.
    PubMed     Text format     Abstract available


  145. WEI AH, Gu ZC, Pu J
    Response to comments of manuscript: Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer?
    Int J Cardiol. 2018 Jul 17. pii: S0167-5273(18)34331.
    PubMed     Text format    


  146. GAIBAZZI N, Siniscalchi C, Reverberi C
    The Heart Sentinel app for detection and automatic alerting in cardiac arrest during outdoor sports: Field tests and ventricular fibrillation simulation results.
    Int J Cardiol. 2018 Jul 16. pii: S0167-5273(18)33416.
    PubMed     Text format    


  147. CAPUTO ML, van Stipdonk A, Illner A, D'Ambrosio G, et al
    The definition of left bundle branch block influences the response to cardiac resynchronization therapy.
    Int J Cardiol. 2018 Jul 16. pii: S0167-5273(18)32495.
    PubMed     Text format     Abstract available


  148. SAEED S, Gerdts E
    Incremental prognostic value of left atrial function indices in the prediction of incident atrial fibrillation in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2018;263:7-8.
    PubMed     Text format    


  149. ODENING KE
    Another step towards a mechanism-based, subtype-specific therapy in long QT syndrome.
    Int J Cardiol. 2018;263:67-68.
    PubMed     Text format    


  150. MELE D, Luisi GA, Ferrari R
    Evaluation of left ventricular systolic function during atrial fibrillation: Is it reliable?
    Int J Cardiol. 2018;263:63-64.
    PubMed     Text format    


  151. DONS M, Jensen JS, Olsen FJ, de Knegt MC, et al
    Global longitudinal strain corrected by RR-interval is a superior echocardiographic predictor of outcome in patients with atrial fibrillation.
    Int J Cardiol. 2018;263:42-47.
    PubMed     Text format     Abstract available


  152. MODIN D, Olsen FJ, Pedersen S, Jensen JS, et al
    Measures of left atrial function predict incident atrial fibrillation in STEMI patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2018;263:1-6.
    PubMed     Text format     Abstract available


  153. RIVAUD MR, Baartscheer A, Verkerk AO, Beekman L, et al
    Enhanced late sodium current underlies pro-arrhythmic intracellular sodium and calcium dysregulation in murine sodium channelopathy.
    Int J Cardiol. 2018;263:54-62.
    PubMed     Text format     Abstract available


  154. BORIANI G, Proietti M, Laroche C, Diemberger I, et al
    Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot gener
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(17)38059.
    PubMed     Text format     Abstract available


  155. ZIUPA D, Menza M, Koppermann S, Moss R, et al
    Electro-mechanical (dys-)function in long QT syndrome type 1.
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)31662.
    PubMed     Text format     Abstract available


  156. MARZONA I, Proietti M, Farcomeni A, Romiti GF, et al
    Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)33433.
    PubMed     Text format     Abstract available


  157. SAKHI R, Yap SC, Michels M, Schinkel AFL, et al
    Evaluation of a novel automatic screening tool for determining eligibility for a subcutaneous implantable cardioverter-defibrillator.
    Int J Cardiol. 2018 Jul 6. pii: S0167-5273(18)33603.
    PubMed     Text format     Abstract available


  158. KHEIRI B, Osman M, Abdalla A, Haykal T, et al
    Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)32169.
    PubMed     Text format     Abstract available


  159. PROIETTI M
    Evolving concepts in atrial fibrillation epidemiology: Advancing knowledge about cardiovascular health in sub-Saharan Africa.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)33362.
    PubMed     Text format    


  160. HU WS, Hsieh MH, Lin CL
    Comparisons of changes in the adapted diabetes complications severity index and CHA2DS2-VASc score for atrial fibrillation risk stratification in patients with type 2 diabetes mellitus: A nationwide cohort study.
    Int J Cardiol. 2018 Jul 3. pii: S0167-5273(18)32963.
    PubMed     Text format     Abstract available


  161. PROTONOTARIOS A, Elliott PM
    Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation.
    Int J Cardiol. 2018 Jul 2. pii: S0167-5273(18)33478.
    PubMed     Text format    


  162. BURLACU A, Covic A
    'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
    Int J Cardiol. 2018;262:43-44.
    PubMed     Text format    


  163. GENOVESI S, Slaviero G, Porcu L, Casu G, et al
    Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population.
    Int J Cardiol. 2018;262:38-42.
    PubMed     Text format     Abstract available


  164. TITTL L, Endig S, Marten S, Reitter A, et al
    Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119).
    Int J Cardiol. 2018;262:85-91.
    PubMed     Text format     Abstract available


  165. MULLERTZ KM, Christiansen MK, Broendberg AK, Pedersen LN, et al
    Outcome of clinical management in relatives of sudden cardiac death victims.
    Int J Cardiol. 2018;262:45-50.
    PubMed     Text format     Abstract available


    June 2018
  166. COHEN AT, Hill NR, Luo X, Masseria C, et al
    A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants.
    Int J Cardiol. 2018 Jun 30. pii: S0167-5273(17)37924.
    PubMed     Text format     Abstract available


  167. WENG CJ, Li CH, Liao YC, Lin CC, et al
    Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort study.
    Int J Cardiol. 2018 Jun 26. pii: S0167-5273(18)33463.
    PubMed     Text format     Abstract available


  168. AYABE K, Goto S
    High rate of death in patients with atrial fibrillation -Results from EORP-AF Pilot General Registry.
    Int J Cardiol. 2018 Jun 22. pii: S0167-5273(18)33076.
    PubMed     Text format    


  169. TOSO E, Peyracchia M, Matta M, D'Ascenzo F, et al
    Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(18)30865.
    PubMed     Text format     Abstract available


  170. ANDERSSON NW, Svanstrom H, Lund M, Pasternak B, et al
    Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(17)35612.
    PubMed     Text format     Abstract available


  171. ARIZA-SOLE A, Guerrero C, Formiga F
    Bayes syndrome: Improving risk stratification in chronic heart failure?
    Int J Cardiol. 2018 Jun 18. pii: S0167-5273(18)33213.
    PubMed     Text format    


  172. SPOSATO LA, Lopes RD
    Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
    Int J Cardiol. 2018;261:99-100.
    PubMed     Text format    


  173. LI Y, Pastori D, Guo Y, Wang Y, et al
    Risk factors for new-onset atrial fibrillation: A focus on Asian populations.
    Int J Cardiol. 2018;261:92-98.
    PubMed     Text format     Abstract available


  174. HSIEH CY, Lee CH, Wu DP, Sung SF, et al
    Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke.
    Int J Cardiol. 2018;261:68-72.
    PubMed     Text format     Abstract available


  175. CHAO TF, Chen SA
    What to do when patients having a high risk of new-onset atrial fibrillation are identified?
    Int J Cardiol. 2018;261:101-102.
    PubMed     Text format    


  176. BORIANI G, Ziacchi M, Nesti M, Battista A, et al
    Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15years?
    Int J Cardiol. 2018;261:119-129.
    PubMed     Text format     Abstract available


  177. FENDER AC, Dobrev D
    Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33661.
    PubMed     Text format    


  178. GOETTE A
    Uninterrupted NOAC therapy in patients undergoing catheter ablation of atrial fibrillation: "Dual anticoagulant therapy" ready for primetime or systematic overtreatment?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33663.
    PubMed     Text format    


  179. ZHAO Y, Lu Y, Qin Y
    A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation.
    Int J Cardiol. 2018 Jun 8. pii: S0167-5273(18)32747.
    PubMed     Text format     Abstract available


  180. TRAN HV, Erskine NA, Nguyen HL, McManus DD, et al
    Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome.
    Int J Cardiol. 2018 Jun 5. pii: S0167-5273(17)37883.
    PubMed     Text format     Abstract available


  181. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Text format     Abstract available


  182. KOHNO T, Kimura T, Fukunaga K, Yamasawa W, et al
    Prevalence and clinical characteristics of obstructive- and central-dominant sleep apnea in candidates of catheter ablation for atrial fibrillation in Japan.
    Int J Cardiol. 2018;260:99-102.
    PubMed     Text format     Abstract available


  183. TSE G, Liu T, Baranchuk A
    Authors' reply: Low prevalence of inter-atrial block in the general population from China: A possible reason for its low rates of atrial fibrillation.
    Int J Cardiol. 2018;260:112.
    PubMed     Text format    


  184. SUN GZ, Wang HY, Zhou Y, Sun YX, et al
    Low prevalence of inter-atrial block in the general population from China: A possible reason for its low rates of atrial fibrillation.
    Int J Cardiol. 2018;260:111.
    PubMed     Text format    


  185. SHIZUTA S, Kawaji T, Kimura T
    Reply to "Should we isolate superior vena cava and to ablate cavo-tricuspid isthmus in all patients with atrial fibrillation during pulmtonary vein isolation?"
    Int J Cardiol. 2018;260:110.
    PubMed     Text format    


  186. ORCZYKOWSKI M, Szumowski L
    Should we isolate superior vena cava and to ablate cavo-tricuspid isthmus in all patients with atrial fibrillation during pulmonary vein isolation?
    Int J Cardiol. 2018;260:109.
    PubMed     Text format    


  187. LINZ D, Nalliah C, Kalman J, Sanders P, et al
    Routine screening for sleep apnea in patients with atrial fibrillation: Ready for primetime?
    Int J Cardiol. 2018;260:103-104.
    PubMed     Text format    


  188. CONTE G, Soejima K, de Asmundis C, Chierchia GB, et al
    Value of high-resolution mapping in optimizing cryoballoon ablation of atrial fibrillation.
    Int J Cardiol. 2018 Jun 1. pii: S0167-5273(18)30713.
    PubMed     Text format     Abstract available


  189. RICCIARDI G, Checchi L
    Permanent his bundle pacing: A physiological alternative to conventional right ventricular pacing or just a futile artifice?
    Int J Cardiol. 2018;260:107-108.
    PubMed     Text format    


  190. YE Y, Zhang Z, Sheng X, Wang B, et al
    Upgrade to his bundle pacing in pacing-dependent patients referred for pulse generator change: Feasibility and intermediate term follow up.
    Int J Cardiol. 2018;260:88-92.
    PubMed     Text format     Abstract available


  191. YU P, Hu L, Xie J, Chen S, et al
    O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts.
    Int J Cardiol. 2018;260:74-81.
    PubMed     Text format     Abstract available


    May 2018
  192. MARTINS D, Ovaert C, Khraiche D, Boddaert N, et al
    Myocardial inflammation detected by cardiac MRI in Arrhythmogenic right ventricular cardiomyopathy: A paediatric case series.
    Int J Cardiol. 2018 May 31. pii: S0167-5273(18)31054.
    PubMed     Text format     Abstract available


  193. CHELU MG, Li N
    Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet?
    Int J Cardiol. 2018 May 30. pii: S0167-5273(18)32813.
    PubMed     Text format    


  194. CARMO AAL, de Sousa MR, Agudelo JF, Boersma E, et al
    Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies.
    Int J Cardiol. 2018 May 29. pii: S0167-5273(18)30210.
    PubMed     Text format     Abstract available


  195. BEN-DOV N, Newman D, Crystal E
    Robotic magnetic catheter navigation as a first step in the automation of the ablation procedures for ventricular arrhythmia.
    Int J Cardiol. 2018 May 26. pii: S0167-5273(18)33283.
    PubMed     Text format    


  196. MUTHALALY RG, Koplan BA, Albano A, North C, et al
    Low population prevalence of atrial fibrillation in rural Uganda: A community-based cross-sectional study.
    Int J Cardiol. 2018 May 24. pii: S0167-5273(18)31107.
    PubMed     Text format     Abstract available


  197. SHULMAN E, Shah T, Mazori AY, Chudow JJ, et al
    Heart failure and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 May 22. pii: S0167-5273(17)37213.
    PubMed     Text format    


  198. FENDER AC, Dobrev D
    The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes.
    Int J Cardiol. 2018 May 19. pii: S0167-5273(18)33126.
    PubMed     Text format    


  199. ESCOBAR-ROBLEDO LA, Bayes-de-Luna A, Lupon J, Baranchuk A, et al
    Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(18)31019.
    PubMed     Text format     Abstract available


  200. MESQUITA J, Ferreira AM, Cavaco D, Carmo P, et al
    Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure.
    Int J Cardiol. 2018;259:82-87.
    PubMed     Text format     Abstract available


  201. AKKAYA E, Berkowitsch A, Zaltsberg S, Greiss H, et al
    Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: Two-year outcome and predictors of recurrence after a single procedure.
    Int J Cardiol. 2018;259:76-81.
    PubMed     Text format     Abstract available


  202. ROMERO J, Di Biase L
    Empirical cavotricuspid isthmus line for atrial fibrillation ablation is futile "Repetita Iuvant".
    Int J Cardiol. 2018;259:107-108.
    PubMed     Text format    


  203. KOSIUK J, de Potter T, Linz D
    The role of electroanatomical mapping in individualized treatment of paroxysmal atrial fibrillation.
    Int J Cardiol. 2018;259:105-106.
    PubMed     Text format    


  204. YASUDA S, Kaikita K, Ogawa H, Akao M, et al
    Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study.
    Int J Cardiol. 2018 May 2. pii: S0167-5273(17)36755.
    PubMed     Text format     Abstract available


  205. TSATSOPOULOU A
    Arrhythmogenic right ventricular cardiomyopathy and pregnancy.
    Int J Cardiol. 2018;258:199-200.
    PubMed     Text format    


  206. GANDJBAKHCH E, Varlet E, Duthoit G, Fressart V, et al
    Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Int J Cardiol. 2018;258:172-178.
    PubMed     Text format     Abstract available


  207. ABUBAKAR H, Osman M, Akintoye E, Subahi A, et al
    Intra-thoracic Impedance and the Onset of Atrial and Ventricular Tachyarrhythmias: A Meta-analysis.
    Int J Cardiol. 2018;258:144-150.
    PubMed     Text format     Abstract available


  208. WANG L, Bi Y, Yu M, Li T, et al
    Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation.
    Int J Cardiol. 2018;258:138-143.
    PubMed     Text format     Abstract available


  209. BOVEDA S, Chalbia TE, Jacob S, Combes S, et al
    Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter-defibrillators.
    Int J Cardiol. 2018;258:133-137.
    PubMed     Text format     Abstract available


  210. SANTORO F, Stiermaier T, Tarantino N, Guastafierro F, et al
    Diagnostic criteria, left ventricular thrombosis, and QT-interval in Takotsubo syndrome.
    Int J Cardiol. 2018;258:29.
    PubMed     Text format    


  211. BOERSMA LVA
    Optimizing S-ICD implant technique: No pain, the true gain?
    Int J Cardiol. 2018;258:159-160.
    PubMed     Text format    


    April 2018
  212. AMIN AS, Reckman YJ, Arbelo E, Spanjaart AM, et al
    SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Int J Cardiol. 2018 Apr 27. pii: S0167-5273(17)32831.
    PubMed     Text format     Abstract available


  213. ZOPPELLARO G, Zanella L, Denas G, Gennaro N, et al
    Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(18)30527.
    PubMed     Text format    


  214. LUO J, Li H, Qin X, Liu B, et al
    Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Apr 23. pii: S0167-5273(17)37900.
    PubMed     Text format     Abstract available


  215. SILLER-MATULA JM, Pecen L, Patti G, Lucerna M, et al
    Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Int J Cardiol. 2018 Apr 22. pii: S0167-5273(17)37365.
    PubMed     Text format     Abstract available


  216. MASUDA M, Fujita M, Iida O, Okamoto S, et al
    Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2018;257:97-101.
    PubMed     Text format     Abstract available


  217. DE POOTER J, Kamoen V, El Haddad M, Stroobandt R, et al
    Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy.
    Int J Cardiol. 2018;257:84-91.
    PubMed     Text format     Abstract available


  218. BARNETT AS, Cyr DD, Goodman SG, Levitan BS, et al
    Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.
    Int J Cardiol. 2018;257:78-83.
    PubMed     Text format     Abstract available


  219. TSATSOPOULOU A, Bossone E
    Common presentation of rare diseases: Arrhythmogenic right ventricular cardiomyopathy and its mimics.
    Int J Cardiol. 2018;257:371-377.
    PubMed     Text format     Abstract available


  220. MANSORI K, Ayubi E
    Comments on association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Int J Cardiol. 2018;257:32.
    PubMed     Text format    


  221. GOUDIS CA, Vasileiadis IE, Liu T
    CHA2DS2-VASc: An eligible score for atrial fibrillation prediction in chronic obstructive pulmonary disease?
    Int J Cardiol. 2018;257:299.
    PubMed     Text format    


  222. KHAZAEI S, Karami M, Veisani Y
    Comment on "Alcohol and incident atrial fibrillation-A systematic review and meta-analysis".
    Int J Cardiol. 2018;257:117.
    PubMed     Text format    


  223. AYUBI E, Safiri S
    Comments on clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation.
    Int J Cardiol. 2018;257:116.
    PubMed     Text format    


  224. AZADANI PN, Marrouche NF, Wilson BD
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:113-114.
    PubMed     Text format    


  225. DENG Y, Qin F, Liu Q, Wu Z, et al
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:110.
    PubMed     Text format    


  226. SANTORO F, Stiermaier T, Tarantino N, Guastafierro F, et al
    ST-elevation magnitude and evolution in Takotsubo syndrome.
    Int J Cardiol. 2018;257:39.
    PubMed     Text format    


  227. BAI J, Shen D, Wang B, Han Q, et al
    Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
    Int J Cardiol. 2018;257:226.
    PubMed     Text format    


  228. BRAILLON A
    Torsade de Pointes: The tip of the iceberg.
    Int J Cardiol. 2018;257:115.
    PubMed     Text format    


  229. WYLIE J
    Letter to the Editor RE: Incidence of Torsade de Pointes in a tertiary hospital population by Vandael et al.
    Int J Cardiol. 2018;257:111.
    PubMed     Text format    


  230. JIA X, Levine GN, Birnbaum Y
    The CHA2DS2-VASc score: Not as simple as it seems.
    Int J Cardiol. 2018;257:92-96.
    PubMed     Text format     Abstract available


  231. YANG H, Heidendael JF, de Groot JR, Konings TC, et al
    Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines.
    Int J Cardiol. 2018;257:67-74.
    PubMed     Text format     Abstract available


  232. OLIVOTTO I, Finocchiaro G, Maurizi N, Crotti L, et al
    Common presentation of rare cardiac diseases: Arrhythmias.
    Int J Cardiol. 2018;257:351-357.
    PubMed     Text format     Abstract available


  233. LIU S, Guan Z, Zheng X, Meng P, et al
    Impaired left atrial systolic function and inter-atrial dyssynchrony may contribute to symptoms of heart failure with preserved left ventricular ejection fraction: A comprehensive assessment by echocardiography.
    Int J Cardiol. 2018;257:177-181.
    PubMed     Text format     Abstract available


  234. CALLOE K, Broendberg AK, Christensen AH, Pedersen LN, et al
    Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D).
    Int J Cardiol. 2018;257:160-167.
    PubMed     Text format     Abstract available


  235. LAMBIASE PD
    AF stroke risk stratification-can we do better?
    Int J Cardiol. 2018;257:108-109.
    PubMed     Text format    


  236. LI B, Sun C, Qin F, Liu N, et al
    Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Int J Cardiol. 2018;256:39.
    PubMed     Text format    


  237. SUN C, Wang W, Leng T, Shi Y, et al
    Letter regarding Nakamura et al. "Anatomical relationship of coronary sinus/great cardiac vein and left circumflex coronary artery along mitral annulus in atrial fibrillation before radiofrequency catheter ablation using 320-slice CT".
    Int J Cardiol. 2018;256:26.
    PubMed     Text format    


  238. SANCHIS-GOMAR F, Lippi G, Cervellin G, Perez-Quilis C, et al
    PAFIYAMA syndrome evidence in highly trained population.
    Int J Cardiol. 2018;256:10.
    PubMed     Text format    


  239. BRUNETTI ND, Tarantino N, Santoro F, Correale M, et al
    "PAFIYAMA" syndrome; further evidence on a novel clinical entity.
    Int J Cardiol. 2018;256:9.
    PubMed     Text format    


  240. BANDYOPADHYAY D, Ashish K, Hajra A, Ghosh RK, et al
    An interesting insight into breakfast and cardiovascular disease.
    Int J Cardiol. 2018;256:7.
    PubMed     Text format    


    March 2018
  241. HAHAD O, Beutel M, Gori T, Schulz A, et al
    Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study.
    Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)37174.
    PubMed     Text format     Abstract available


  242. HA FJ, Barra S, Brown AJ, Begley DB, et al
    Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
    Int J Cardiol. 2018 Mar 21. pii: S0167-5273(18)31037.
    PubMed     Text format     Abstract available


  243. YU L, Meng G, Huang B, Zhou X, et al
    A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
    Int J Cardiol. 2018;255:92-98.
    PubMed     Text format     Abstract available


  244. MISHIMA RS, Elliott AD, Sanders P, Linz D, et al
    Microbiome and atrial fibrillation.
    Int J Cardiol. 2018;255:103-104.
    PubMed     Text format    


  245. TSUJI Y, Dobrev D
    Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators: Mechanistic and therapeutic considerations to reduce the risk of death.
    Int J Cardiol. 2018;255:101-102.
    PubMed     Text format    


  246. EICKHOLT C
    Finding the right timing in cryoballoon ablation for pulmonary vein isolation.
    Int J Cardiol. 2018;255:99-100.
    PubMed     Text format    


  247. NODA T, Kurita T, Nitta T, Chiba Y, et al
    Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator.
    Int J Cardiol. 2018;255:85-91.
    PubMed     Text format     Abstract available


  248. POTT A, Kraft C, Stephan T, Petscher K, et al
    Time-to-isolation guided titration of freeze duration in 3rd generation short-tip cryoballoon pulmonary vein isolation - Comparable clinical outcome and shorter procedure duration.
    Int J Cardiol. 2018;255:80-84.
    PubMed     Text format     Abstract available


  249. LEE HF, Chan YH, Tu HT, Kuo CT, et al
    The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(17)37808.
    PubMed     Text format     Abstract available


  250. DIEMBERGER I, Fantecchi E, Reggiani MLB, Martignani C, et al
    Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(17)38078.
    PubMed     Text format     Abstract available


  251. PROIETTI M, Romiti GF, Romanazzi I, Farcomeni A, et al
    Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(18)31060.
    PubMed     Text format     Abstract available


  252. SCHEWEL D, Schewel J, Schluter M, Kreidel F, et al
    Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2018 Mar 13. pii: S0167-5273(17)36281.
    PubMed     Text format     Abstract available


  253. BISSON A, Bodin A, Clementy N, Bernard A, et al
    Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
    Int J Cardiol. 2018 Mar 7. pii: S0167-5273(18)30084.
    PubMed     Text format     Abstract available


  254. KAWADA T
    Periodic limb movements of sleep and atrial fibrillation in patients with mild sleep-disordered breathing.
    Int J Cardiol. 2018;254:345.
    PubMed     Text format    


  255. YALTA K, Taylan G, Gurlertop Y
    Atrial fibrillation in the setting of takotsubo cardiomyopathy: Just the tip of the iceberg?
    Int J Cardiol. 2018;254:174.
    PubMed     Text format    


  256. PROIETTI M
    The dangerous combination of atrial fibrillation and hypertension: An urgent need to handle complexity.
    Int J Cardiol. 2018;254:167-169.
    PubMed     Text format    


  257. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    


  258. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study.
    Int J Cardiol. 2018;254:157-161.
    PubMed     Text format     Abstract available


  259. DAN GA, Badila E, Weiss E, Laroche C, et al
    Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
    Int J Cardiol. 2018;254:136-141.
    PubMed     Text format     Abstract available


  260. POPPE KK, Doughty RN, Harwood M, Barber PA, et al
    Identification, risk assessment, and management of patients with atrial fibrillation in a large primary care cohort.
    Int J Cardiol. 2018;254:119-124.
    PubMed     Text format     Abstract available


  261. SANTORO F, Di Biase M, Brunetti ND
    Effect of sex hormones in Takotsubo cardiomyopathy: Just matter of arrhythmias or also outcomes?
    Int J Cardiol. 2018;254:246-247.
    PubMed     Text format    


  262. GIUSTETTO C, Cerrato N, Gaita F
    Drug-induced type 1 Brugada ECG: Lights and shadows.
    Int J Cardiol. 2018;254:170-171.
    PubMed     Text format    


  263. DE LAZZARI M, Perazzolo Marra M
    The myocardial bright signal: The arrhythmogenic link between function and myocardial fibrosis.
    Int J Cardiol. 2018;254:258-259.
    PubMed     Text format    


  264. EL-BATTRAWY I, Zhao Z, Lan H, Schunemann JD, et al
    Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes.
    Int J Cardiol. 2018;254:195-202.
    PubMed     Text format     Abstract available


  265. GATZOULIS KA, Georgopoulos S, Antoniou CK, Anastasakis A, et al
    Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy.
    Int J Cardiol. 2018;254:175-181.
    PubMed     Text format     Abstract available


  266. SHI S, Barajas-Martinez H, Liu T, Sun Y, et al
    Prevalence of spontaneous Brugada ECG pattern recorded at standard intercostal leads: A meta-analysis.
    Int J Cardiol. 2018;254:151-156.
    PubMed     Text format     Abstract available


  267. DELISE P, Allocca G, Sitta N, Migliore F, et al
    Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk?
    Int J Cardiol. 2018;254:142-145.
    PubMed     Text format     Abstract available


    February 2018
  268. TENMA T, Yokoshiki H, Mitsuyama H, Watanabe M, et al
    Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator.
    Int J Cardiol. 2018 Feb 20. pii: S0167-5273(17)37446.
    PubMed     Text format     Abstract available


  269. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    


  270. BEYER-WESTENDORF J, Kreutz R, Posch F, Ay C, et al
    The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease.
    Int J Cardiol. 2018;253:71-77.
    PubMed     Text format     Abstract available


  271. CONTE G, Caputo ML, Volders PGA, Luca A, et al
    Concealed abnormal atrial phenotype in patients with Brugada syndrome and no history of atrial fibrillation.
    Int J Cardiol. 2018;253:66-70.
    PubMed     Text format     Abstract available


  272. NAMMAS W, Kiviniemi T, Schlitt A, Rubboli A, et al
    Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.
    Int J Cardiol. 2018;253:35-39.
    PubMed     Text format     Abstract available


  273. FENDER AC
    PS. It was me all along! Emergence of phosphatidylserine in the procoagulant state in atrial fibrillation.
    Int J Cardiol. 2018 Feb 12. pii: S0167-5273(18)30663.
    PubMed     Text format    


  274. SHIMOKAWA H, Yamashita T, Uchiyama S, Kitazono T, et al
    The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Feb 3. pii: S0167-5273(18)30592.
    PubMed     Text format     Abstract available


  275. BARI V, Ranucci M, De Maria B, Cairo B, et al
    Model-based directional analysis of cardiovascular variability identifies patients developing atrial fibrillation after coronary artery bypass grafting.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)37276.
    PubMed     Text format     Abstract available


  276. LIU FZ, Liao HT, Lin WD, Xue YM, et al
    Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)37479.
    PubMed     Text format     Abstract available


  277. PROIETTI M, Lip GYH
    Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials.
    Int J Cardiol. 2018;252:96-100.
    PubMed     Text format     Abstract available


  278. CHUGH SS
    Heart failure and atrial fibrillation: Can we break this nexus?
    Int J Cardiol. 2018;252:142-143.
    PubMed     Text format    


  279. ZIFF OJ, Carter PR, McGowan J, Uppal H, et al
    The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry.
    Int J Cardiol. 2018;252:117-121.
    PubMed     Text format     Abstract available


  280. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    


  281. DRAGO F
    Postoperative arrhythmias after AVSD repair: The lack of regular periodic rhythm surveillance allows you to see only the tip of the iceberg.
    Int J Cardiol. 2018;252:94-95.
    PubMed     Text format    


  282. KHARBANDA RK, Blom NA, Hazekamp MG, Yildiz P, et al
    Incidence and risk factors of post-operative arrhythmias and sudden cardiac death after atrioventricular septal defect (AVSD) correction: Up to 47years of follow-up.
    Int J Cardiol. 2018;252:88-93.
    PubMed     Text format     Abstract available


  283. BRONZETTI G, Brighenti M, Mariucci E, Fabi M, et al
    Upside-down position for the out of hospital management of children with supraventricular tachycardia.
    Int J Cardiol. 2018;252:106-109.
    PubMed     Text format     Abstract available


    January 2018
  284. KAPA S, Vaidya V, Hodge DO, McLeod CJ, et al
    Right ventricular dysfunction in congenitally corrected transposition of the great arteries and risk of ventricular tachyarrhythmia and sudden death.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)36055.
    PubMed     Text format     Abstract available


  285. TE ALD, Lo LW, Lin YJ, Chang SL, et al
    Vasovagal responses during cryoballoon pulmonary vein isolation in paroxysmal atrial fibrillation predict favorable mid-term outcomes.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)36027.
    PubMed     Text format     Abstract available


  286. CAVALLARI I, Ruff CT, Nordio F, Deenadayalu N, et al
    Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2018 Jan 26. pii: S0167-5273(17)35262.
    PubMed     Text format     Abstract available


  287. JOLOBE OMP
    Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
    Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
    PubMed     Text format    


  288. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation impacts the outcome in Takotsubo syndrome.
    Int J Cardiol. 2018;251:57.
    PubMed     Text format    


  289. GALLAGHER C, Hendriks JML, Lau DH, Sanders P, et al
    Alcohol and atrial fibrillation.
    Int J Cardiol. 2018;251:56.
    PubMed     Text format    


  290. YANG Y, Hu D, Peng D
    Should small-to-moderate alcohol consumption be recommended for healthy middle-aged women?
    Int J Cardiol. 2018;251:55.
    PubMed     Text format    


  291. PARREIRA L, Marinheiro R
    "Excessive" atrial ectopy is worse than "frequent" atrial ectopy.
    Int J Cardiol. 2018;251:54.
    PubMed     Text format    


  292. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    


  293. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    


  294. FERLINI M, Rossini R
    Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage.
    Int J Cardiol. 2018;251:42-44.
    PubMed     Text format     Abstract available


  295. KISS A, Podesser BK
    Low-dose of relaxin protects against arrhythmias and adverse left ventricle remodeling.
    Int J Cardiol. 2018;250:60-61.
    PubMed     Text format    


  296. BEIERT T, Knappe V, Tiyerili V, Stockigt F, et al
    Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.
    Int J Cardiol. 2018;250:21-28.
    PubMed     Text format     Abstract available


    December 2017
  297. PASTORI D, Pignatelli P, Sciacqua A, Perticone M, et al
    Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Int J Cardiol. 2017 Dec 24. pii: S0167-5273(17)36573.
    PubMed     Text format     Abstract available


  298. HEIJMAN J, Kirchner D, Kunze F, Chretien EM, et al
    Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.
    Int J Cardiol. 2017 Dec 22. pii: S0167-5273(17)37262.
    PubMed     Text format     Abstract available


  299. ANTZELEVITCH C, Di Diego JM, Argenziano M
    Tpeak-Tend as a predictor of ventricular arrhythmogenesis.
    Int J Cardiol. 2017;249:75-76.
    PubMed     Text format    


  300. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    


  301. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    


  302. SPARTALIS M, Tzatzaki E, Dimitroulis D, Spartalis E, et al
    The emerging role of hybrid ablation for atrial fibrillation.
    Int J Cardiol. 2017;249:257.
    PubMed     Text format    


  303. BERTAGLIA E, Anselmino M, Zorzi A, Russo V, et al
    NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Int J Cardiol. 2017;249:179-183.
    PubMed     Text format     Abstract available


  304. DING M, Fratiglioni L, Johnell K, Fastbom J, et al
    Atrial fibrillation and use of antithrombotic medications in older people: A population-based study.
    Int J Cardiol. 2017;249:173-178.
    PubMed     Text format     Abstract available


  305. CHIU SN, Huang SC, Wang JK, Lu CW, et al
    Implantable cardioverter defibrillator therapy in repaired tetralogy of Fallot after pulmonary valve replacement: Implications for the mechanism of ventricular arrhythmia.
    Int J Cardiol. 2017;249:156-160.
    PubMed     Text format     Abstract available


  306. TSATSOPOULOU A
    Desmoplakin: Highlights on a left ventricular arrhythmogenic disorder.
    Int J Cardiol. 2017;249:324-325.
    PubMed     Text format    


  307. WAKILI R, Dobrev D
    Response to: "The emerging role of hybrid ablation for ablation" by Spartialis M. et al.
    Int J Cardiol. 2017;249:258.
    PubMed     Text format    


  308. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    


  309. ESTEVE-PASTOR MA, Rivera-Caravaca JM, Roldan V, Vicente V, et al
    Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.
    Int J Cardiol. 2017 Dec 14. pii: S0167-5273(17)34423.
    PubMed     Text format     Abstract available


  310. BUIATTI A, von Olshausen G, Martens E, Schinke K, et al
    Balloon angioplasty versus stenting for pulmonary vein stenosis after pulmonary vein isolation for atrial fibrillation: A meta-analysis.
    Int J Cardiol. 2017 Dec 6. pii: S0167-5273(17)35398.
    PubMed     Text format     Abstract available


  311. LIEDER H, Breithardt G, Heusch G
    Fatal attraction - A brief pathophysiology of the interaction between atrial fibrillation and myocardial ischemia.
    Int J Cardiol. 2017 Dec 6. pii: S0167-5273(17)36897.
    PubMed     Text format     Abstract available


  312. LINZ D, Elliott AD, Marwick TH, Sanders P, et al
    Biomarkers and new-onset atrial fibrillation to assess atrial cardiomyopathy.
    Int J Cardiol. 2017;248:208-210.
    PubMed     Text format    


  313. NORTAMO S, Ukkola O, Lepojarvi S, Kentta T, et al
    Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Int J Cardiol. 2017;248:173-178.
    PubMed     Text format     Abstract available


  314. LIMONGELLI G, Sarubbi B
    Atrial arrhythmias in adults with congenital heart disease. Listening to your heart sound can save your life.
    Int J Cardiol. 2017;248:159-160.
    PubMed     Text format    


    November 2017
  315. REUSSER A, Blum S, Aeschbacher S, Eggimann L, et al
    QTc interval, cardiovascular events and mortality in patients with atrial fibrillation.
    Int J Cardiol. 2017 Nov 24. pii: S0167-5273(17)35267.
    PubMed     Text format     Abstract available


  316. STROKER E, Kupics K, de Asmundis C, Mugnai G, et al
    Atrial fibrillation ablation with the second generation cryoballoon: Multicenter propensity score matched comparison between freezing strategies.
    Int J Cardiol. 2017 Nov 22. pii: S0167-5273(17)35978.
    PubMed     Text format     Abstract available


  317. PERTICONE M, Sciacqua A, Tripepi G, Miceli S, et al
    Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation.
    Int J Cardiol. 2017 Nov 20. pii: S0167-5273(17)34491.
    PubMed     Text format     Abstract available


  318. YUCEL O, Yucel H, Zorlu A
    D-dimer is a predictor of cardiovascular death, and new-onset atrial fibrillation in patients with systolic heart failure.
    Int J Cardiol. 2017;247:39.
    PubMed     Text format    


  319. FOSSATI C, Volterrani M, Punzo N, Campolongo G, et al
    Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation.
    Int J Cardiol. 2017;247:37.
    PubMed     Text format    


  320. BAI F, Qin F, Liu Q, Tu T, et al
    Is the increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias accurate?
    Int J Cardiol. 2017;247:23.
    PubMed     Text format    


  321. MERT KU, Dural M, Mert GO
    Is electrical cardioversion doable in atrial fibrillation without transesophageal echocardiography?
    Int J Cardiol. 2017;247:20.
    PubMed     Text format    


  322. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    


  323. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    


  324. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    


  325. LIU Q, Qin F, Liu N, Tu T, et al
    Is the new risk factor algorithm accurate to predict frequent premature ventricular contraction-induced cardiomyopathy?
    Int J Cardiol. 2017;247:27.
    PubMed     Text format    


  326. PHILLIPS KP
    Response by Phillips KP et al. to letter regarding article 'Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation'.
    Int J Cardiol. 2017;247:22.
    PubMed     Text format    


  327. MAURIZI N, Olivotto I, Cecchi F
    Reply to: Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Int J Cardiol. 2017;246:55.
    PubMed     Text format    


  328. QIN F, Liu Q, Liu Z
    Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Int J Cardiol. 2017;246:54.
    PubMed     Text format    


  329. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    


  330. GALLAGHER C, Hendriks JML, Elliott AD, Wong CX, et al
    Alcohol and incident atrial fibrillation - A systematic review and meta-analysis.
    Int J Cardiol. 2017;246:46-52.
    PubMed     Text format     Abstract available


    October 2017
  331. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available


  332. GILLJAM T, Haugaa KH, Jensen HK, Svensson A, et al
    Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.
    Int J Cardiol. 2017 Oct 21. pii: S0167-5273(17)34381.
    PubMed     Text format     Abstract available


  333. POLIN B, Behar N, Galand V, Auffret V, et al
    Clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation.
    Int J Cardiol. 2017;245:168-173.
    PubMed     Text format     Abstract available


  334. LAHEWALA S, Arora S, Patel P, Kumar V, et al
    Atrial fibrillation: Utility of CHADS2 and CHA2DS2-VASc scores as predictors of readmission, mortality and resource utilization.
    Int J Cardiol. 2017;245:162-167.
    PubMed     Text format     Abstract available


  335. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    


  336. TADROS R, Wilde AAM
    Revisiting the sensitivity of sodium channel blocker testing in Brugada syndrome using obligate transmittance.
    Int J Cardiol. 2017;245:183-184.
    PubMed     Text format    


  337. ALHEDE C, Lauridsen TK, Johannessen A, Dixen U, et al
    The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.
    Int J Cardiol. 2017 Oct 9. pii: S0167-5273(17)33443.
    PubMed     Text format     Abstract available


  338. LEINONEN JT, Crotti L, Djupsjobacka A, Castelletti S, et al
    The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34464.
    PubMed     Text format     Abstract available


  339. BANERAS J, Ferreira-Gonzalez I, Marsal JR, Barrabes JA, et al
    Short-term exposure to air pollutants increases the risk of ST elevation myocardial infarction and of infarct-related ventricular arrhythmias and mortality.
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34210.
    PubMed     Text format     Abstract available


  340. TSE G, Wong CW, Gong M, Wong WT, et al
    Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)35239.
    PubMed     Text format     Abstract available


  341. AGNIHOTRI K, Pothineni NV, Charilaou P, Vaidya VR, et al
    Impact of atrial fibrillation on outcomes with motor vehicle accidents.
    Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)33412.
    PubMed     Text format     Abstract available


  342. MAKOWSKI M, Baj Z
    Platelet reactivity and mean platelet volume as new biomarkers in risk stratification in patient with atrial fibrillation.
    Int J Cardiol. 2017;244:297.
    PubMed     Text format    


  343. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    


  344. ZHAO Y, Qin F, He B, Liu X, et al
    Is atrial fibrillation itself the cause of increased platelet reactivity intrinsically?
    Int J Cardiol. 2017;244:205.
    PubMed     Text format    


  345. MAKOWSKI M, Baj Z
    Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Int J Cardiol. 2017;244:204.
    PubMed     Text format    


  346. HEIJMAN J, Dobrev D, Crijns HJGM
    Targeting supraventricular ectopic complexes: Which approach should be used and how does it affect atrial fibrillation?
    Int J Cardiol. 2017;244:202-203.
    PubMed     Text format    


    September 2017
  347. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available


  348. POLOVINA M, Dikic D, Vlajkovic A, Vilotijevic M, et al
    Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)34881.
    PubMed     Text format     Abstract available


  349. YAMADA S, Lo LW, Chen SA
    Reply to letter to the editor: "A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation".
    Int J Cardiol. 2017;243:282.
    PubMed     Text format    


  350. YI X, Feng G, Jiang X
    A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation.
    Int J Cardiol. 2017;243:281.
    PubMed     Text format    


  351. WAKILI R, Dobrev D
    Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy?
    Int J Cardiol. 2017;243:276-278.
    PubMed     Text format    


  352. HUIKURI HV
    Prediction of benefits from prophylactic implantable cardioverter-defibrillator therapy.
    Int J Cardiol. 2017;243:274-275.
    PubMed     Text format    


  353. FENDER AC, Dobrev D
    Dynamic balance of platelet reactivity in atrial fibrillation PARtially unravelled.
    Int J Cardiol. 2017;243:272-273.
    PubMed     Text format    


  354. DAN GA
    Atrial fibrillation: Applying evidence out of the box.
    Int J Cardiol. 2017;243:270-271.
    PubMed     Text format    


  355. SALIH M, Smer A, Charnigo R, Ayan M, et al
    Colchicine for prevention of post-cardiac procedure atrial fibrillation: Meta-analysis of randomized controlled trials.
    Int J Cardiol. 2017;243:258-262.
    PubMed     Text format     Abstract available


  356. POURTAU L, Sellal JM, Lacroix R, Poncelet P, et al
    Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.
    Int J Cardiol. 2017;243:216-222.
    PubMed     Text format     Abstract available


  357. RODRIGUEZ-MANERO M, Lopez-Pardo E, Cordero A, Kredieh O, et al
    Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area.
    Int J Cardiol. 2017;243:211-215.
    PubMed     Text format     Abstract available


  358. KAWAJI T, Shizuta S, Morimoto T, Aizawa T, et al
    Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience.
    Int J Cardiol. 2017 Sep 15. pii: S0167-5273(17)33302.
    PubMed     Text format     Abstract available


  359. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    


  360. YANG Y, Liu Q, Liu Z, Zhou S, et al
    Is flat QRS complex in lead aVL the characteristic of ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus?
    Int J Cardiol. 2017;242:47.
    PubMed     Text format    


  361. NEEFS J, van den Berg NWE, Limpens J, Berger WR, et al
    Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."
    Int J Cardiol. 2017;242:23.
    PubMed     Text format    


  362. ALEXANDRE J, Sezai A, Milliez P
    Comment on "Aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al.
    Int J Cardiol. 2017;242:22.
    PubMed     Text format    


  363. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    


  364. LENNERZ C, Barman M, Tantawy M, Sopher M, et al
    Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis.
    Int J Cardiol. 2017 Sep 1. pii: S0167-5273(17)32407.
    PubMed     Text format     Abstract available


  365. WEI X, An Q
    Prognostic value of left atrial size and function in adults with tetralogy of Fallot.
    Int J Cardiol. 2017;242:36.
    PubMed     Text format    


    August 2017
  366. PROIETTI M, Laroche C, Nyvad O, Haberka M, et al
    Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)32291.
    PubMed     Text format     Abstract available


  367. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
    Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
    PubMed     Text format     Abstract available


  368. BELHASSEN B, Milman A
    Syncope in Brugada syndrome: A plea for thorough anamnesis and EPS. The lessons from our journey in the region of Piedmont, Italy.
    Int J Cardiol. 2017;241:241-242.
    PubMed     Text format    


  369. RHODES AC, Murray B, Tichnell C, James CA, et al
    Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
    Int J Cardiol. 2017 Aug 14. pii: S0167-5273(17)31856.
    PubMed     Text format     Abstract available


  370. WANG M, Li S, Zhou X, Huang B, et al
    Increased inflammation promotes ventricular arrhythmia through aggravating left stellate ganglion remodeling in a canine ischemia model.
    Int J Cardiol. 2017 Aug 12. pii: S0167-5273(17)31266.
    PubMed     Text format     Abstract available


  371. DE LUCA L, Casella G, Rubboli A, Gonzini L, et al
    Recent trends in management and outcome of patients with acute coronary syndromes and atrial fibrillation.
    Int J Cardiol. 2017 Aug 10. pii: S0167-5273(17)32498.
    PubMed     Text format     Abstract available


  372. MASUDA K, Ishizu T, Gosho M, Aonuma K, et al
    Reply to: Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias: Bias due to the data sparsity.
    Int J Cardiol. 2017 Aug 8. pii: S0167-5273(17)33784.
    PubMed     Text format    


  373. DOMINGUEZ F, Climent V, Zorio E, Ripoll-Vera T, et al
    Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Int J Cardiol. 2017 Aug 7. pii: S0167-5273(17)33243.
    PubMed     Text format     Abstract available


  374. SABERIAN S, Badin A, Siebert V, Roy A, et al
    Prevalence and predictors of inappropriate anticoagulation in patients with a CHA2DS2-VASc score of 0 and atrial fibrillation.
    Int J Cardiol. 2017 Aug 2. pii: S0167-5273(17)31619.
    PubMed     Text format     Abstract available


  375. TINKER A
    The mechanisms of ventricular arrhythmia in Chagas disease.
    Int J Cardiol. 2017;240:372-373.
    PubMed     Text format    


  376. WALDO AL
    Atrial fibrillation and atrial flutter: Two sides of the same coin!
    Int J Cardiol. 2017;240:251-252.
    PubMed     Text format    


  377. ROMERO J, Estrada R, Holmes A, Goodman-Meza D, et al
    Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillation.
    Int J Cardiol. 2017;240:246-250.
    PubMed     Text format     Abstract available


    July 2017
  378. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Association between gamma-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2017 Jul 21. pii: S0167-5273(16)34879.
    PubMed     Text format     Abstract available


  379. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available


  380. STIERMAIER T, Santoro F, Eitel C, Graf T, et al
    Prevalence and prognostic relevance of atrial fibrillation in patients with Takotsubo syndrome.
    Int J Cardiol. 2017 Jul 18. pii: S0167-5273(17)33182.
    PubMed     Text format     Abstract available


  381. ZHANG N, Tse G, Liang X, Li G, et al
    Telomere length: A newly marker for predicting atrial fibrillation?
    Int J Cardiol. 2017;239:21.
    PubMed     Text format    


  382. AYUBI E, Safiri S, Mansournia MA
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias: Bias due to the data sparsity.
    Int J Cardiol. 2017;239:20.
    PubMed     Text format    


  383. ZENG J, Wang X
    Metabolic disorder caused by antipsychotic treatment may facilitate the development of atrial fibrillation.
    Int J Cardiol. 2017;239:14.
    PubMed     Text format    


  384. ROSATO E, Tubani L, Gigante A
    QTc interval prolongation in systemic sclerosis.
    Int J Cardiol. 2017;239:34.
    PubMed     Text format    


  385. DE LUCA G, Bosello SL, Canestrari G, Cavalli G, et al
    QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk.
    Int J Cardiol. 2017;239:33.
    PubMed     Text format    


  386. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    


  387. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available


  388. BAYKANER T, Zaman JAB, Rogers AJ, Navara R, et al
    Spatial relationship of sites for atrial fibrillation drivers and atrial tachycardia in patients with both arrhythmias.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)31816.
    PubMed     Text format     Abstract available


  389. SUN C, Qin F, Tu T, Liu Q, et al
    Is antiarrhythmic medication superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation?
    Int J Cardiol. 2017 Jul 6. pii: S0167-5273(17)33752.
    PubMed     Text format    


  390. AZADANI PN, King JB, Kheirkhahan M, Chang L, et al
    Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)32655.
    PubMed     Text format    


    June 2017
  391. CHOU RH, Lo LW, Leu HB
    Autonomic dysfunction plays a decisive role in the arrhythmia initiation, whereas metabolic disorders facilitate further atrial remodeling in antipsychotic-related atrial fibrillation.
    Int J Cardiol. 2017 Jun 30. pii: S0167-5273(17)30750.
    PubMed     Text format    


  392. OKAWA K, Miyoshi T, Tsukuda S, Hara S, et al
    Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.
    Int J Cardiol. 2017 Jun 19. pii: S0167-5273(17)32623.
    PubMed     Text format     Abstract available


  393. CROTTI L, Kotta MC
    The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies.
    Int J Cardiol. 2017;237:45-48.
    PubMed     Text format     Abstract available


  394. MIYAZAKI S, Ebana Y, Liu L, Nakamura H, et al
    Chromosome 4q25 variants and recurrence after second-generation cryoballoon ablation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)30813.
    PubMed     Text format     Abstract available


  395. STYLES K, Sapp J Jr, Gardner M, Gray C, et al
    The influence of sex and age on ventricular arrhythmia in a population-based registry.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32392.
    PubMed     Text format     Abstract available


  396. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available


  397. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
    Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
    PubMed     Text format     Abstract available


  398. ELLERMANN C, Wolfes J, Kochhauser S, Dechering DG, et al
    Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndrome.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)32130.
    PubMed     Text format     Abstract available


  399. CARMO J, Ferreira J, Costa F, Carmo P, et al
    Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
    PubMed     Text format     Abstract available


  400. CHANG KW, Arbit B, Hsu JC
    Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.
    Int J Cardiol. 2017 Jun 2. pii: S0167-5273(17)32256.
    PubMed     Text format     Abstract available


  401. STEFFEL J, Ruff CT, Hamershock RA, Murphy SA, et al
    First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2017 Jun 2. pii: S0167-5273(17)32088.
    PubMed     Text format     Abstract available


  402. BELLMANN B, Fiebach JB, Guttmann S, Lin T, et al
    Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
    Int J Cardiol. 2017 Jun 1. pii: S0167-5273(17)32336.
    PubMed     Text format     Abstract available


  403. D'ANGELO RN, Pickett CC
    Diagnostic yield of device interrogation in the evaluation of syncope in an elderly population.
    Int J Cardiol. 2017;236:164-167.
    PubMed     Text format     Abstract available


  404. LUO B, Zhou G, Guo X, Liu X, et al
    Long-term outcome of catheter ablation for left posterior fascicular ventricular tachycardia with the development of left posterior fascicular block and characteristics of repeat procedures.
    Int J Cardiol. 2017;236:203-208.
    PubMed     Text format     Abstract available


  405. TURAGAM MK, Afzal MR, Reddy M, Pillarisetti J, et al
    Practice variation in the re-initiation of dofetilide: An observational study.
    Int J Cardiol. 2017;236:221-225.
    PubMed     Text format     Abstract available


  406. CHANG JH, Chang SL, Hong PD, Chen PN, et al
    Epigallocatechin-3-gallate modulates arrhythmogenic activity and calcium homeostasis of left atrium.
    Int J Cardiol. 2017;236:174-180.
    PubMed     Text format     Abstract available


  407. HAMMWOHNER M, Goette A
    Kidney diseases and NOAC therapy: Is there a light at the end of the tunnel?
    Int J Cardiol. 2017;236:162-163.
    PubMed     Text format    


    May 2017
  408. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available


  409. DA COSTA A, Guichard JB, Romeyer-Bouchard C
    Reply to the letter to Editor "Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?"
    Int J Cardiol. 2017;235:202.
    PubMed     Text format    


  410. LIANG J, Cha Y
    Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?
    Int J Cardiol. 2017;235:201.
    PubMed     Text format    


  411. MALLIKETHI-REDDY S, Akintoye E, Trehan N, Sharma S, et al
    Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations.
    Int J Cardiol. 2017;235:114-117.
    PubMed     Text format     Abstract available


  412. TAKAHASHI Y, Izumi C, Miyake M, Imanaka M, et al
    Actual management and prognosis of severe isolated tricuspid regurgitation associated with atrial fibrillation without structural heart disease.
    Int J Cardiol. 2017 May 11. pii: S0167-5273(16)32716.
    PubMed     Text format     Abstract available


  413. ALHEDE C, Lauridsen TK, Johannessen A, Dixen U, et al
    Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(17)31514.
    PubMed     Text format     Abstract available


  414. CASTELLETTI S, Vischer AS, Syrris P, Crotti L, et al
    Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(17)30578.
    PubMed     Text format     Abstract available


  415. WONG CX, Gan SW, Lee SW, Gallagher C, et al
    Atrial fibrillation and risk of hip fracture: A population-based analysis of 113,600 individuals.
    Int J Cardiol. 2017 May 5. pii: S0167-5273(16)34388.
    PubMed     Text format     Abstract available


    April 2017
  416. LIU J, Wang N, Qin L, Liu J, et al
    Integrating genotypes in the SAMe-TT2R2 score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin.
    Int J Cardiol. 2017 Apr 29. pii: S0167-5273(17)30949.
    PubMed     Text format     Abstract available


  417. SUNDBOLL J, Hovath-Puho E, Adelborg K, Ording A, et al
    Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
    Int J Cardiol. 2017 Apr 26. pii: S0167-5273(17)30248.
    PubMed     Text format     Abstract available


  418. XIE J, Chahal CAA, Covassin N, Schulte PJ, et al
    Periodic limb movements of sleep are associated with an increased prevalence of atrial fibrillation in patients with mild sleep-disordered breathing.
    Int J Cardiol. 2017 Apr 22. pii: S0167-5273(16)34493.
    PubMed     Text format     Abstract available


  419. KIMURA Y, Noda T, Matsuyama TA, Otsuka Y, et al
    Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30192.
    PubMed     Text format     Abstract available


  420. HUNG Y, Lo LW, Lin YJ, Chang SL, et al
    Characteristics and long-term catheter ablation outcome in long-standing persistent atrial fibrillation patients with non-pulmonary vein triggers.
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(16)33852.
    PubMed     Text format     Abstract available


  421. BARKAS F, Elisaf M, Korantzopoulos P, Tsiara S, et al
    The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)31069.
    PubMed     Text format     Abstract available


  422. HATEGAN L, Csanyi B, Ordog B, Kakonyi K, et al
    A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)30089.
    PubMed     Text format     Abstract available


  423. BAYKANER T, Zografos TA, Zaman JAB, Pantos I, et al
    Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi.
    Int J Cardiol. 2017 Apr 19. pii: S0167-5273(17)30158.
    PubMed     Text format     Abstract available


  424. O'BRIEN B, Zafar H, De Freitas S, Sharif F, et al
    Transseptal puncture - Review of anatomy, techniques, complications and challenges.
    Int J Cardiol. 2017;233:12-22.
    PubMed     Text format     Abstract available


  425. PARK KM, Im SI, Park SJ, Kim JS, et al
    Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy.
    Int J Cardiol. 2017;233:37-42.
    PubMed     Text format     Abstract available


  426. SPITZER SG, Leitz P, Langbein A, Karolyi L, et al
    Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34442.
    PubMed     Text format     Abstract available


  427. YAMASAKI H, Lustgarten D, Cerkvenik J, Birnie D, et al
    Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter?
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)33104.
    PubMed     Text format     Abstract available


  428. MURA M, Mehta A, Ramachandra CJ, Zappatore R, et al
    The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(17)30298.
    PubMed     Text format     Abstract available


  429. ANSELMINO M, Garberoglio L, Gili S, Bertaglia E, et al
    Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study.
    Int J Cardiol. 2017 Apr 8. pii: S0167-5273(16)32868.
    PubMed     Text format     Abstract available


  430. ARENAS DE LARRIVA AP, Norby FL, Chen LY, Soliman EZ, et al
    Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
    Int J Cardiol. 2017 Apr 6. pii: S0167-5273(16)34419.
    PubMed     Text format     Abstract available


  431. MERY B, Guichard JB, Guy JB, Vallard A, et al
    Atrial fibrillation in cancer patients: Hindsight, insight and foresight.
    Int J Cardiol. 2017 Apr 5. pii: S0167-5273(17)30307.
    PubMed     Text format     Abstract available


  432. TANG LH, Kikkenborg Berg S, Christensen J, Lawaetz J, et al
    Patients' preference for exercise setting and its influence on the health benefits gained from exercise-based cardiac rehabilitation.
    Int J Cardiol. 2017;232:33-39.
    PubMed     Text format     Abstract available


  433. KOSTIC T, Momcilovic S, Perisic ZD, Apostolovic SR, et al
    Manifestations of Lyme carditis.
    Int J Cardiol. 2017;232:24-32.
    PubMed     Text format     Abstract available


  434. ABRICH VA, Ramakrishna H, Mehta A, Mookadam F, et al
    The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis.
    Int J Cardiol. 2017;232:243-246.
    PubMed     Text format     Abstract available


    March 2017
  435. KIM IS, Sohn J, Lee SJ, Park JK, et al
    Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implantable cardioverter defibrillators: Vulnerable patients to air pollution.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(17)30052.
    PubMed     Text format     Abstract available


  436. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Text format     Abstract available


  437. BRUNETTI ND, De Gennaro L, Caldarola P, Gaglione A, et al
    Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?
    Int J Cardiol. 2017 Mar 22. pii: S0167-5273(17)31385.
    PubMed     Text format    


  438. FEMIA G, Sy RW, Puranik R
    Systematic review: Impact of the new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2017 Mar 19. pii: S0167-5273(17)30613.
    PubMed     Text format     Abstract available


  439. CAPPATO R, Ali H
    Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Int J Cardiol. 2017 Mar 18. pii: S0167-5273(17)31691.
    PubMed     Text format     Abstract available


  440. CAMM AJ
    Hopes and disappointments with antiarrhythmic drugs.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(17)31664.
    PubMed     Text format     Abstract available


  441. TOPAZ G, Flint N, Steinvil A, Finkelstein A, et al
    Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(16)32197.
    PubMed     Text format     Abstract available


  442. SCHWARTZ PJ, Dagradi F
    Red Bull(R): Red flag or red herring?
    Int J Cardiol. 2017;231:179-180.
    PubMed     Text format    


  443. LI H, Qingyao, Bingshen, Shu M, et al
    Application of 3D printing technology to left atrial appendage occlusion.
    Int J Cardiol. 2017;231:258-263.
    PubMed     Text format     Abstract available


  444. BIFFI M, Ziacchi M, Ricci RP, Facchin D, et al
    Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation.
    Int J Cardiol. 2017;230:275-280.
    PubMed     Text format     Abstract available


  445. DA COSTA A, Guichard JB, Maillard N, Romeyer-Bouchard C, et al
    Substantial superiority of Niobe ES over Niobe II system in remote-controlled magnetic pulmonary vein isolation.
    Int J Cardiol. 2017;230:319-323.
    PubMed     Text format     Abstract available


  446. SUN GZ, Ye N, Chen YT, Zhou Y, et al
    Early repolarization pattern in the general population: Prevalence and associated factors.
    Int J Cardiol. 2017;230:614-618.
    PubMed     Text format     Abstract available


    February 2017
  447. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31114.
    PubMed     Text format     Abstract available


  448. CAY S, Aras D, Topaloglu S, Ozcan F, et al
    Early repolarization syndrome and Brugada syndrome: Similar or different?
    Int J Cardiol. 2017;229:9.
    PubMed     Text format    


  449. MODI R, Patted SV, Halkati PC, Porwal S, et al
    CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Int J Cardiol. 2017;228:1002-1006.
    PubMed     Text format     Abstract available


  450. PATEL N, Donahue C, Shenoy A, Patel A, et al
    Obstructive sleep apnea and arrhythmia: A systemic review.
    Int J Cardiol. 2017;228:967-970.
    PubMed     Text format     Abstract available


  451. YUAN X, Du J, Liu Q, Zhang L, et al
    Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
    Int J Cardiol. 2017;228:958-966.
    PubMed     Text format     Abstract available


  452. TE AL, Lin YJ, Chen YY, Chung FP, et al
    Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up.
    Int J Cardiol. 2017;228:68-73.
    PubMed     Text format     Abstract available


  453. FROMMEYER G, Kohnke A, Ellermann C, Dechering DG, et al
    Experimental evidence for a severe proarrhythmic potential of levosimendan.
    Int J Cardiol. 2017;228:583-587.
    PubMed     Text format     Abstract available


  454. LEE G, McLellan AJ, Hunter RJ, Lovell MJ, et al
    Panoramic characterization of endocardial left atrial activation during human persistent AF: Insights from non-contact mapping.
    Int J Cardiol. 2017;228:406-411.
    PubMed     Text format     Abstract available


  455. JUNELL A, Thomas J, Hawkins L, Sklenar J, et al
    Screening entire healthcare system ECG database: Association of deep terminal negativity of P wave in lead V1 and ECG referral with mortality.
    Int J Cardiol. 2017;228:219-224.
    PubMed     Text format     Abstract available


    January 2017
  456. ZACHARIASARDOTTIR S, Risgaard B, Agesen FN, Jabbari R, et al
    Sudden cardiac death and coronary disease in the young: A nationwide cohort study in Denmark.
    Int J Cardiol. 2017 Jan 28. pii: S0167-5273(16)33099.
    PubMed     Text format     Abstract available


  457. BOTTO GL, Padeletti L, Covino G, Pieragnoli P, et al
    Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)33105.
    PubMed     Text format     Abstract available


  458. BANERJEE K, Ghosh RK, Kamatam S, Banerjee A, et al
    Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
    Int J Cardiol. 2017;227:556-564.
    PubMed     Text format     Abstract available


  459. PADALA SK, Peaslee S, Sidhu MS, Steckman DA, et al
    Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis.
    Int J Cardiol. 2017;227:565-570.
    PubMed     Text format     Abstract available


  460. CHO MS, Kwon CH, Nam GB, Lee WS, et al
    Characteristics of early repolarization parameters and prognostic implications in the general ambulatory Korean population.
    Int J Cardiol. 2017;227:571-576.
    PubMed     Text format     Abstract available


  461. DA COSTA A, Axiotis A, Romeyer-Bouchard C, Abdellaoui L, et al
    Transcatheter leadless cardiac pacing: The new alternative solution.
    Int J Cardiol. 2017;227:122-126.
    PubMed     Text format     Abstract available


  462. TONDATO F, Bazzell J, Schwartz L, Mc Donald BW, et al
    Safety and interaction of patients with implantable cardiac defibrillators driving a hybrid vehicle.
    Int J Cardiol. 2017;227:318-324.
    PubMed     Text format     Abstract available


  463. KIUCHI MG, Chen S, Purerfellner H
    Incidence of ventricular arrhythmic events in CKD patients with ICD.
    Int J Cardiol. 2017;227:312-317.
    PubMed     Text format     Abstract available


  464. KIMURA M, Fujisawa T, Aizawa Y, Matsuhashi N, et al
    An RyR2 mutation found in a family with a short-coupled variant of torsade de pointes.
    Int J Cardiol. 2017;227:367-369.
    PubMed     Text format    


  465. SEZAI A, Akahoshi T, Osaka S, Yaoita H, et al
    Sleep disordered breathing in cardiac surgery patients: The NU-SLEEP trial.
    Int J Cardiol. 2017;227:342-346.
    PubMed     Text format     Abstract available


  466. LI N, Wang Q, Sibrian-Vazquez M, Klipp RC, et al
    Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.
    Int J Cardiol. 2017;227:668-673.
    PubMed     Text format     Abstract available


  467. CHIU SN, Wu WL, Lu CW, Wu KL, et al
    Special electrophysiological characteristics of pediatric idiopathic ventricular tachycardia.
    Int J Cardiol. 2017;227:595-601.
    PubMed     Text format     Abstract available


  468. CHANAVIRUT R, Tong-Un T, Jirakulsomchok D, Wyss JM, et al
    Abnormal autonomic nervous system function in rural Thai men: A potential contributor to their high risk of sudden unexplained nocturnal death syndrome.
    Int J Cardiol. 2017;226:87-92.
    PubMed     Text format     Abstract available


    December 2016
  469. CHANG KH, Chang WC, Su CS, Liu TJ, et al
    Vasospastic myocardial infarction complicated with ventricular tachycardia in a patient with hyperthyroidism.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)32087.
    PubMed     Text format    


  470. BERTEL N, Witassek F, Puhan M, Erne P, et al
    Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34533.
    PubMed     Text format     Abstract available


    November 2016
  471. OMAR HR, Guglin M
    Mitral annulus diameter is the main echocardiographic correlate of S3 gallop in acute heart failure.
    Int J Cardiol. 2016;228:834-836.
    PubMed     Text format    


  472. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available


  473. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available


    September 2016
  474. LIN WL, Lo LW, Chen HR, Lai CT, et al
    Sleep-related changes in cardiovascular autonomic regulation in left coronary artery ligation rats: Neural mechanism facilitating arrhythmia after myocardial infarction.
    Int J Cardiol. 2016;225:65-72.
    PubMed     Text format     Abstract available


    August 2016
  475. ERGUN G, Dogan V, Basaran O, Biteker M, et al
    Metoprolol vs ivabradine in patients with mitral stenosis.
    Int J Cardiol. 2016;223:108.
    PubMed     Text format    


  476. AKIMA T, Koyama T, Munakata M, Shibata M, et al
    Absence of reperfusion-induced arrhythmia in patients with ST-segment elevation myocardial infarction treated using postconditioning with lactate-enriched blood.
    Int J Cardiol. 2016;222:780-781.
    PubMed     Text format    


    June 2016
  477. HONG-TAOYUAN, Yang M, Zhong L, Lee YH, et al
    Ventricular premature contraction associated with mitral valve prolapse.
    Int J Cardiol. 2016;221:1144-1149.
    PubMed     Text format     Abstract available


    April 2016
  478. SLAWUTA A, Mazur G, Malecka B, Gajek J, et al
    Permanent His bundle pacing - An optimal treatment method in heart failure patients with AF and narrow QRS.
    Int J Cardiol. 2016;214:451-452.
    PubMed     Text format    


    March 2016
  479. STEWART S, Riegel B, Boyd C, Ahamed Y, et al
    Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
    Int J Cardiol. 2016;212:1-10.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: